Corporate Information | Press & Media | For Investors

[Press Release] Guardian Research Network and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer

by

 Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.

[Press Release] ThinkGenetic Closes $1.5M Angel Round of Funding

by

ThinkGenetic, Inc., makers of an artificial intelligence-driven SymptomMatcher™​ for genetic disorders, today announced the successful close of its angel round of funding for $1.5M.

ThinkGenetic Partners with Genome Medical

by

New Partnership Strengthens ThinkGenetic’s Continued Effort to Reduce Time to Diagnosis In an influential move for the genetics community, ThinkGenetic (ThinkGenetic.com) and Genome Medical (GenomeMedical.com),  a nationwide specialty medical practice […]

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.